Issue 003 | U.S. Pilot | US

CDIO

Cardio Diagnostics Holdings, Inc.

Screen state: Passing Source state: Verified 10-Q | 2026-05-15 Filing currency: USD
Internal NCAV Discount 35.3%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
7,744,615USD
Total Liabilities
655,972USD
NCAV
7,088,643USD
Cash
0USD
NCAV per share
2.40USD/share
Evidence
5 annual | 17 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Evaluated
12
Triggered
2
Unavailable
7
Requires inspection Negative OCF -1,562,212
Latest
-1,562,2122026-03-31
Comparison
n/a
Change
n/a

Basis: latest reporting-period cash from operations < 0

Source periods: SEC 10-Q 2026-03-31 · 0001553350-26-000089

Supporting observation Current Ratio > 1.5 15.76
Latest
15.762026-03-31
Comparison
1.5
Change
n/a

Basis: current assets / current liabilities; strong if > 1.5

Source periods: SEC 10-Q 2026-03-31 · 0001553350-26-000089

7 unavailable checks — inspect missing inputs
High Debt (short-term debt + long-term debt) / ordinary equity >= 50%
Low Debt (short-term debt + long-term debt) / ordinary equity < 20%
Material 1Y Share Increase 1Y share change >= +2% using the same share-count source
NCAV Growing equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
No Material 1Y Share Increase 1Y share change > -2% and <= +1% using the same share-count source
Non-Positive Equity ordinary shareholders equity <= 0
Share Count Reduced 1Y share change <= -2% using the same share-count source

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis

Verified split events: reverse 5.0 on 2024-11-15; reverse 30.0 on 2025-12-31; reverse 1.0009886307464162 on 2026-03-31; reverse 30.0 on 2026-03-31

Known Unknowns

Only 17 quarterly periods available from Data Vault for this company.

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
Revenue 14,825 34,890 17,065 950 901
Operating Income -6,484,078 -8,365,877 -7,242,459 -4,548,451 -620,448
Net Income -6,498,167 -8,383,453 -8,376,834 -4,660,985 -620,448
Cash From Operations -5,726,833 -4,993,104 -5,672,175 -5,090,968 -585,291
Capex -187,317 -214,765 -575,663 n/a n/a
Free Cash Flow -5,914,150 -5,207,869 -6,247,838 n/a n/a
Cash And Equivalents 0 0 0 0 0
Accounts Receivable 8,126 18,612 4,960 0 901
Inventory n/a n/a n/a n/a n/a
Total Current Assets 5,920,703 8,790,782 2,765,680 5,885,887 806,682
Total Assets 7,766,415 10,615,312 4,462,365 6,249,478 65,807,166
Total Current Liabilities 604,839 631,695 841,142 1,947,770 124,434
Total Liabilities 793,061 1,057,524 1,504,241 1,947,770 124,434
Shareholders Equity 6,973,354 9,557,788 2,958,124 4,301,708 682,732
Shares Outstanding 98,552 57,882 4,793 2,134 8,215
Shares Outstanding Diluted n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 58,323 29,851 2,816 685 258
Weighted Avg Shares Basic 58,323 29,851 2,816 685 258
Net Share Count Change (Normalized) 3000.9% 657.3% 56.6% 485.5% Insufficient evidence
Ownership Claim Change (Normalized) -96.8% -86.8% -36.1% -82.9% Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Only 17 quarterly periods available from Data Vault for this company.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
Revenue 2,680 3,555 2,855 7,475 940 4,512 6,580 7,870 15,928 5,310 10,030 1,725 0 950 0 0 0
Operating Income -1,784,837 -1,463,222 -1,711,597 -1,678,699 -1,630,560 -1,516,402 -1,408,967 -1,282,460 -4,158,048 -1,541,998 -1,444,191 -2,553,141 -1,703,129 -3,657,489 -165,291 -498,577 -227,094
Net Income -1,788,158 -1,465,368 -1,714,536 -1,683,199 -1,635,064 -1,519,308 -1,412,566 -1,287,995 -4,163,584 -1,388,929 -1,932,382 -4,022,905 -1,032,618 -4,147,940 202,269 -492,651 -222,663
Cash From Operations -1,562,212 -1,361,849 -1,393,418 -1,571,465 -1,400,101 -1,392,295 -1,157,359 -1,210,400 -1,233,050 -1,685,677 -1,044,599 -1,292,832 -1,649,067 -4,503,952 -105,978 -335,028 -146,010
Capex -1,760 0 -162,834 -18,696 -5,787 -3,638 -23,246 -167,896 -19,985 n/a -12,591 n/a n/a n/a 0 n/a n/a
Free Cash Flow -1,563,972 -1,361,849 -1,556,252 -1,590,161 -1,405,888 -1,395,933 -1,180,605 -1,378,296 -1,253,035 n/a -1,057,190 n/a n/a n/a -105,978 n/a n/a
Cash And Equivalents 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Current Assets 7,744,615 5,920,703 6,927,472 8,703,348 10,535,493 8,790,782 2,627,172 2,138,526 2,589,274 2,765,680 4,522,298 6,254,718 8,138,031 5,885,887 228,052 186,119 635,710
Total Liabilities 655,972 793,061 637,331 671,848 904,998 1,057,524 795,276 922,529 1,290,762 1,504,241 3,675,576 3,848,380 5,129,496 1,947,770 631,748 229,434 180,542
Shares Outstanding 2,959,469 98,552 2,027 1,957 1,930 57,882 8,978 5,315 5,036 4,793 4,555 2,614 2,215 2,112 361 361 361
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 2,840,778 60,641 1,951 1,930 1,872 43,661 5,426 5,019 4,679 4,207 2,643 2,274 2,119 3,087,683 1,468 1,205 938
Weighted Avg Shares Basic 2,840,778 60,641 1,951 1,930 1,872 43,661 5,426 5,019 4,679 4,207 2,643 2,274 2,119 3,087,683 1,468 1,205 938
Net Share Count Change (Normalized) 4766.9% 3000.9% 1.5% 0.1% -96.2% 657.3% 30.1% Insufficient evidence Insufficient evidence 56.6% 17.3% 16.3% 1.1% 485.5% Insufficient evidence Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) -97.9% -96.8% -1.5% -0.1% 2542.5% -86.8% -23.2% Insufficient evidence Insufficient evidence -36.1% -14.8% -14.0% -1.1% -82.9% Insufficient evidence Insufficient evidence Insufficient evidence
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 7,744,615USD us-gaap:AssetsCurrent 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001870144/companyfacts.json
Data Vault | sec/companyfacts/cik=0001870144/companyfacts.json
Total Liabilities 655,972USD us-gaap:Liabilities 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001870144/companyfacts.json
Data Vault | sec/companyfacts/cik=0001870144/companyfacts.json
Cash 0USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001870144/companyfacts.json
Data Vault | sec/companyfacts/cik=0001870144/companyfacts.json
Shares Outstanding 2,959,469 us-gaap:CommonStockSharesOutstanding 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001870144/companyfacts.json
Data Vault | sec/companyfacts/cik=0001870144/companyfacts.json
NCAV 7,088,643USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 2.40USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 35.3% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
Local evidence | The Data Vault
CIK
0001870144
Company ID
n/a
Selected Annual Source
Data Vault | sec/companyfacts/cik=0001870144/companyfacts.json
Selected Quarterly Source
Data Vault | sec/companyfacts/cik=0001870144/companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
18
Imported At
2026-08-02T05:40:53+00:00
Rendered At
2026-08-16T03:29:48+00:00

Run Audit

Mary Run
8f67c1da7de642feb640d04491409c50
Mary As Of
2026-07-25
Accession
0001553350-26-000089
CIK
0001870144
Mary Filing Date
2026-05-15
Filing Currency
USD
Internal Discount
35.3%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=8f67c1da7de642feb640d04491409c50; mary_as_of=2026-07-25; mary_filing_date=2026-05-15; mary_accession=0001553350-26-000089; mary_cik=0001870144; gnni_supporting_filing_date=2026-05-15; internal_discount=0.352884; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive